Search for: "Anda Pharmaceuticals, Inc"
Results 401 - 420
of 607
Sorted by Relevance
|
Sort by Date
7 Dec 2023, 1:47 pm
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
26 Sep 2009, 1:57 pm
Their filing an ANDA riled AstraZeneca to assert infringement of 4,879,288. [read post]
6 Oct 2008, 11:24 am
Aventis Pharmaceuticals (Fed. [read post]
7 Jul 2010, 3:21 pm
Apotex, Inc., C.A. [read post]
29 Aug 2011, 12:30 pm
09-1039), and Actavis, Inc. v. [read post]
13 Jun 2011, 5:32 pm
Several other generic drug manufacturers submitted ANDAs to FDA containing Paragraph IV certifications to Orange Book-listed patents on GEMZAR, including APP Pharmaceuticals, Inc. [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
25 Apr 2011, 3:16 pm
The following is excerpted from an April 25, 2010 press release from POZEN published by Business Wire: POZEN Inc. [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on… [read post]
21 Sep 2009, 2:30 am
Patent holder Eli Lilly and Company has claimed infringement by Sandoz, Inc. and others. [read post]
13 Apr 2011, 5:13 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2-10-cv-00836 (E.D. [read post]
3 Nov 2010, 7:00 am
Walters On October 25, Amphastar Pharmaceuticals, Inc. [read post]
17 May 2007, 9:09 am
Teva Pharmaceuticals USA Inc., No. 06-0282, 22 BNA Toxic Law Rptr. #20 (S.D. [read post]
21 Apr 2023, 7:07 am
Amgen Inc., v. [read post]
1 Apr 2013, 8:29 am
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
27 Sep 2010, 12:59 am
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
20 Dec 2012, 12:20 pm
Apotex Corp. is a United States affiliate of the Canadian Company Apotex Inc. [read post]
15 Jun 2014, 6:18 pm
Procedural HistoryZydus Pharmaceuticals USA, Inc. [read post]
20 Sep 2021, 1:23 am
§ 271(e)(2)(C). [2] AbbVie Inc. v. [read post]
